A recent study demonstrated that IGFBP3, which is considered a potential biomarker for radiosensitivity, enhances cell death in oral squamous cell carcinoma cells during radiotherapy by inducing an increase in ROS through the activation of NF-κB and the production of cytokines26. This evidence concerns the gene IGFBP3 and oral cavity squamous cell carcinoma.